Xalatan
Marketedupdated 2mo agoby Greenstone LLC
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 4 approved and 3 investigational indications.
all catalysts(6)
approval · 6
Jul 19, 2011
approval
LATANOPROST — FDA approval
Xalatan
→
Sep 22, 2014
approval
LATANOPROST — FDA approval
Xalatan
→
Dec 17, 2025
approval
LATANOPROST — FDA approval
Xalatan
→
Jan 30, 2026
approval
LATANOPROST — FDA approval
Xalatan
→
Jan 30, 2026
approval
LATANOPROST — FDA approval
Xalatan
→
Jan 30, 2026
approval
LATANOPROST — FDA approval
Xalatan
→
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that